Fycompa (Eisai Inc.)


Welcome to the PulseAid listing for the Fycompa drug offered from Eisai Inc.. This Noncompetitive AMPA Glutamate Receptor Antagonist [EPC],AMPA Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Eisai Inc.
NON-PROPRIETARY NAME: perampanel
SUBSTANCE NAME: PERAMPANEL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Noncompetitive AMPA Glutamate Receptor Antagonist [EPC],AMPA Receptor Antagonists [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-10-22
END MARKETING DATE: 0000-00-00


Fycompa HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFycompa from Eisai Inc.
LABELER NAME: Eisai Inc.
DEA SCHEDULE: CIII
ACTIVE STRENGTH: 2(mg/1)
START MARKETING DATE: 2012-10-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62856-272_a33a96b4-f178-4071-b357-2ed4ce07bdf8
PRODUCT NDC: 62856-272
APPLICATION NUMBER: NDA202834

Other PERAMPANEL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Eisai Inc.Fycompa